Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Apricus Biosciences, Inc.

TRADE

NASDAQ: APRIHealthcare / Drug Manufacturers - Other / USA
0.35+0.02+6.06%Vol 6 518 6091Y Perf -81.01%
Oct 17th, 2018 14:45
BID0.34 ASK0.35
Open0.33 Previous Close0.33
Pre-Market0.31 After-Trading0.35
 -0.02 -6.06%  0.02 6.06%
Target Price
2.65 
Analyst Rating
Hold 3.00
Potencial %
679.41 
Finscreener Ranking
★★+ —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★★+     54.81
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★+     47.94
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)8 
Earnings Rating
Buy
Price Range Ratio 52wk %
3.24 
Earnings Date
1st Nov 2018

Today's Price Range

0.330.42

 

52wk Range

0.253.34

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Month
17.86%
3 Months
-13.16%
6 Months
17.86%
1 Year
-81.01%
3 Years
-78.71%
5 Years
-83.66%

Quotes

Name / TickerPriceChg.Chg.%
APRI0.350.02006.06
AAPL221.03-1.1200-0.50
GOOG1 114.39-6.8900-0.61
MSFT110.56-0.4400-0.40
XOM81.200.00000.00
WFC54.550.82001.53
JNJ139.342.78002.04
FB158.900.12000.08
GE12.240.14001.16
JPM110.021.40001.29
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 3.60
Current Ratio 3.70
Long Term Debt to Total Capital -
Total Debt to Equity 0.00
Interest Coverage -108.80
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin79.20
EBIT Margin-697.20
EBITDA Margin-677.00
Pre-tax Profit Margin-305.20
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio 0.70
PB Ratio 1.29
PS Ratios 79.92
Price to Cash Flow 26.00
Price to Free Cash Flow -1.10
Cash Flow Per Share -0.55
Price to Tangible Book1.29
Book Value per Share0.23
Enterprise Value (in ths.)-5
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)2 271.53
ROE last 12 Months -180.36
Return on Assets (5Y Avg) -157.30
ROA last 12 Months -133.35
Return on Capital (5Y Avg) -
ROC last 12 Months -182.62
Return on invested Capital Q -47.58
Return on invested Capital Y-45.76
Assets Turnover0.00
Receivables Turnover0.00
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -53.21
Revenue Growth 5 Years -27.17
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018--0.10-
Q01 2018-0.10-0.14-40.00
Q04 2017-0.13-0.16-23.08
Q03 2017-0.15-0.30-100.00
Q02 2017-0.17-0.1511.76
Q01 20171.24-0.44-135.48
Q04 20160.01-0.04-500.00
Q03 2016-0.70-0.1972.86
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.100.00-
9/2018 QR-0.100.00-
12/2018 FY-0.400.00-
12/2018 FY-0.39-130.47Negative
Next Report Date1st Nov 2018
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume6 518 609
Shares Outstanding (in ths.)23 440
Trades Count4 219
Dollar Volume2 265 223
Avg. Volume1 016 898
Avg. Weekly Volume1 105 170
Avg. Monthly Volume899 373
Avg. Quarterly Volume712 021

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

63%38%

Bearish Bullish

71%29%

Bearish Bullish

60%40%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingHold
3.00
Hold
3.00
Hold
3.00

There are no comments yet.

News

x